Completed PHASE2 INTERVENTIONAL 2-arm NCT03674385

Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate

Evaluation of the Clinical Outcome of Vitamin E as Adjuvant Therapy in Patients With Clomiphene Citrate Resistant Polycystic Ovary Syndrome

Sponsor: Ain Shams University

Conditions Clomiphene Citrate Resistant Polycystic Ovary Syndrome

Interventions Clomiphene Citrate Metformin vitamin E

Updated 6 times since 2018 Last updated: Jul 8, 2020 Started: Jul 19, 2018 Primary completion: Mar 25, 2019 Completion: Mar 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Clomiphene Citrate Resistant Polycystic Ovary Syndrome and is currently completed. Ain Shams University leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Aug 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Apr 2019 — Aug 2020 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Oct 2018 — Apr 2019 [monthly]

Recruiting PHASE2

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University
Misr University for Science and Technology

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Banī Suwayf, Egypt